Gefapixant in two randomised dose-escalation studies in chronic cough

Gefapixant has previously demonstrated efficacy in the treatment of refractory chronic cough at a high daily dose. The current investigations explore efficacy and tolerability of gefapixant, a P2X3 receptor antagonist, for the treatment of chronic cough using a dose-escalation approach. Two randomis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The European respiratory journal 2020-03, Vol.55 (3), p.1901615
Hauptverfasser:	Smith, Jaclyn A, Kitt, Michael M, Butera, Peter, Smith, Steven A, Li, Yuping, Xu, Zhi Jin, Holt, Kimberley, Sen, Shilpi, Sher, Mandel R, Ford, Anthony P
Format:	Artikel
Sprache:	eng
Schlagworte:	Chronic Disease Cough - drug therapy Double-Blind Method Humans Pyrimidines Sulfonamides Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!